Skip to main content
. 2022 Aug 3;30(2):253–272. doi: 10.1007/s40199-021-00414-8

Table 2.

Percentage of gated cells in G0/G1, S, and G2/M phases. Asterisk (*) represents a significant difference compared to ctrl1 (p < 0.05). Dagger () represents a significant difference compared to ctrl2 (p < 0.05). Each test was conducted in triplicate (n = 3)

Leptin + AP (Methanol)
Leptin AP Cis G0/G1 (%) S (%) G2/M (%)
ctrl1 76.23 ± 0.47 7.83 ± 0.42 14.30 ± 0.26
ctrl2 72.70 ± 0.61* 10.67 ± 0.21* 14.87 ± 0.45
ic10 IC10 62.77 ± 0.67 15.53 ± 0.78 19.77 ± 0.06
ic25 IC25 61.63 ± 1.64 21.13 ± 0.55 15.50 ± 0.95
cisplatin IC10 20.30 ± 0.35 44.37 ± 0.32 31.83 ± 0.49
Adipocyte CM + AP (Methanol)
CM AP Cis G0/G1 (%) S (%) G2/M (%)
ctrl1 79.40 ± 0.69 4.17 ± 0.45 15.13 ± 0.32
ctrl2 72.93 ± 2.27 7.43 ± 0.42* 17.97 ± 1.80
ic10 IC10 62.47 ± 6.92 18.83 ± 6.82 17.03 ± 0.51
ic25 IC25 37.10 ± 5.94 44.07 ± 5.95 17.00 ± 0.78
cisplatin IC10 31.40 ± 3.92 22.07 ± 1.12 43.57 ± 3.53
Leptin = 100 ng/mL; CM = 10%; APE2 IC10 = 24.11 µg/mL, IC25 = 42.11 µg/mL; Cisplatin IC10 = 4.11 µg/mL